Pharma Pulse 11/6/24: Balancing Personalized Targeting with Protecting Consumers, What Do SMA Caregivers Want? & more

Balancing Personalized Targeting with Protecting Consumer Privacy

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discusses the need to balance personalized targeting with the ethical imperative to protect consumer privacy.

What Do SMA Caregivers Want?

In a response to a survey, caregivers of people with spinal muscular atrophy identified the risk of severe adverse events and the need for permanent ventilation as the most important factors in treatment decisions. Access to treatment, including cost and availability, ranked third.

From A.I. to Musk’s Brain Chips, the F.D.A.’s Device Unit Faces Rapid Change

The new director overseeing medical devices will confront criticisms about hasty approvals as she ushers in revolutionary technology.

NJ Bio and Charles River Announce a Strategic Alliance to Advance ADC Development and Manufacturing Services

NJ Bio, Inc. and Charles River Laboratories, Inc. announced a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody drug conjugates (ADCs).

Envirotainer on LinkedIn

Our Chief Commercial Officer,Delphine Perridy Boile, recently spoke with Pharmaceutical Commerce Magazine about the rapid evolution in pharma driven by unserved patient needs, new technologies, and AI in drug discovery.

She highlights the importance of precise temperature control and customized logistics, especially for biologics and personalized medicines, as the industry adapts to bring innovative treatments to patients faster.

Read the full interview below for more insights on the future of pharma cold chain and sustainability.

#Envirotainer #PharmaInnovation #ColdChainLogistics

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs